Clinical Trial For Type 2 Diabetes Patients

Annapolis Internal Medicine is excited to announce a new clinical trial for patients with Type 2 diabetes. People recently diagnosed with Type 2 diabetes are at higher risk for developing pancreatic cancer.
Bluestar Genomics is studying a new blood test to identify pancreatic cancer in people with recently
diagnosed Type 2 diabetes.

You may be a candidate for this research study if the following apply:

  • You are 50 years of age or older
  • You’ve recently been diagnosed with Type 2 diabetes within 6 months

If you’re interested in participating in this clinical trial, contact Annapolis Internal Medicine today for more information. Check out the link below for more details on the trial.

Clinical Trial Details

phone number